 SHANGHAI, March 17, 2021 PRNewswire -- 111, Inc. 111 or the Company Nasdaq: YI, a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, announced today it has entered into a strategic cooperation agreement with BeiGene, Ltd. NASDAQ:BGNE; HKEX:06160, a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide. 